Dipeptidyl peptidase 4 inhibitors
A drug may be classified by the chemical type of the active ingredient or by the way it is used to treat a particular condition. Each drug can be classified into one or more drug classes.
Dipeptidyl peptidase 4 inhibitors are oral antidiabetes agents that help control blood sugar levels in Type 2 diabetes patients. They inhibit the enzyme dipeptidyl peptidase 4 and regulate the levels of insulin the body produces after a meal. Dipeptidyl peptidase 4 inhibition results in increased activity of incretins, which inhibits glucagon release. This leads to increased insulin secretion, decreased gastric emptying and therefore decreased blood sugar levels.
|Drug Name ( View by: Brand | Generic )||Reviews||Ratings|
|saxagliptin systemic (Pro, More...)
|sitagliptin systemic (Pro, More...)
|linagliptin systemic (Pro, More...)
|alogliptin systemic (Pro, More...)
Medical conditions associated with dipeptidyl peptidase 4 inhibitors: